BRCA1, Ki67, and β-Catenin Immunoexpression Is Not Related to Differentiation, Platinum Response, or Prognosis in Women With Low- and High-Grade Serous Ovarian Carcinoma.

MLA

Sallum, Luis Felipe, et al. “BRCA1, Ki67, and β-Catenin Immunoexpression Is Not Related to Differentiation, Platinum Response, or Prognosis in Women With Low- and High-Grade Serous Ovarian Carcinoma.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 28, no. 3, Mar. 2018, pp. 437–47. EBSCOhost, https://doi.org/10.1097/IGC.0000000000001205.

APA

Sallum, L. F., Andrade, L., Bastos Eloy da Costa, L., Ramalho, S., Ferracini, A. C., Natal, R. de A., Brito, A. B. C., Sarian, L. O., & Derchain, S. (2018). BRCA1, Ki67, and β-Catenin Immunoexpression Is Not Related to Differentiation, Platinum Response, or Prognosis in Women With Low- and High-Grade Serous Ovarian Carcinoma. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 28(3), 437–447. https://doi.org/10.1097/IGC.0000000000001205

Chicago

Sallum, Luis Felipe, Liliana Andrade, Larissa Bastos Eloy da Costa, Susana Ramalho, Amanda Canato Ferracini, Rodrigo de Andrade Natal, Angelo Borsarelli Carvalho Brito, Luis Otávio Sarian, and Sophie Derchain. 2018. “BRCA1, Ki67, and β-Catenin Immunoexpression Is Not Related to Differentiation, Platinum Response, or Prognosis in Women With Low- and High-Grade Serous Ovarian Carcinoma.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 28 (3): 437–47. doi:10.1097/IGC.0000000000001205.